medizin

Today is International Clinical Trials Day. Let’s celebrate this event and raise awareness about clinical trials while expressing our gratitude to all clinical research professionals worldwide.

Last week, the first workshop in the BosomShield project was hosted by the IBIB PAN (Institute of Biocybernetics and Biomedical Engineering of the Polish Academy of Sciences) in Warsaw.
Our Ph.D. candidate, Yaqeen Ali, presented his achievements towards federated learning approaches for breast cancer classification. The entire workshop discussion focused on how AI is shaping medical imaging, particularly in breast cancer. We would like to express our gratitude to IBIB PAN (https://ibib.pl/en/) for organizing this inspiring session.

More information on the Marie Sklodowska-Curie Doctorate network Bosomshield: https://bosomshield.eu/

Did you know that Parkinson’s disease is the fastest-growing brain disease? At the same time, Parkinson’s disease is so variable, almost no 2 individuals’ symptoms and progression are the same. That is why at mediri, we are working every day to improve the diagnosis and therapy of Parkinson’s disease using advanced MR Imaging and Focused Ultrasound techniques.

For more details, you can have a look at this publication on automatic planning of MR-guided transcranial focused ultrasound treatment or this review article on blood-brain barrier dysfunction imaging.

We proudly announce that mediri has once again received the Digital Innovator 2024 award from CHIP in the category ”medical technology“.
In times of digitization, CHIP and data analysis specialist Globis Consulting have studied the innovative power of German companies and institutes in digitization. CHIP is known as one of the top recommended brands. See the full ranking here.

Today is International Day of Radiology to promote the seismic impact of radiology on medicine – earlier detection, fewer surgeries, and game-changing treatment outcomes. Analyzing radiological images in multi centric clinical studies can be challenging considering standardization and patient data privacy.
Mediri is constantly evolving its image data management platform mTRIAL for secure and reliable central reads in clinical studies. Currently, mTRIAL is getting ready for RANO 2.0 evaluation of low- and high-grade gliomas according to the recently published update by Wen et al. Stay posted.

RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults | Journal of Clinical Oncology (ascopubs.org)

New office. New Neighbours. New view.
It’s done! We have offically moved to Am Taubenfeld 21/1 in 69123 Heidelberg.

We proudly announce the release of our new mTRIAL version. For the first time it incorporates a webbased comprehensive DICOM image viewer for platform independent and real time access of clinical trial data. Central read workflow planning and execution has been upgraded for even more reliable and efficient review of radiological data. mTRIAL 3.4. – ready to support your next image based clinical trial.

If you have two minutes, take a look at this aerzteblatt article about artificial intelligence that is mentioning mediri and the DeepRAY project.

The easiest way to use FreeSurfer for brain volume measurements? Upload your FLAIR images to mTRIAL and enjoy the magic.
Interested? Don’t hesitate to contact us.